NBY Competitors & Alternatives
Compare NovaBay Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
NBY
Main Stock$1.95
Tradestie Score
43
Market Cap
$8.23M
Revenue Growth
-0.8%
Analyst Upside
-56.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.66
|
$133.50M | - | 56 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.07
|
$114.01M | - | 68 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$26.49
|
$110.20M | - | 58 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.97
|
$67.94M | - | 56 | Compare |
|
SINT
SiNtx Technologies, Inc. Common Stock
|
$1.88
|
$11.23M | - | 31 | Compare |
|
SNGX
Soligenix, Inc. Common Stock
|
$0.38
|
$10.38M | - | 46 | Compare |
|
OGEN
Oragenics Inc.
|
$0.49
|
$5.86M | 0.5 | 49 | Compare |
|
INDP
Indaptus Therapeutics, Inc. Common Stock
|
$3.85
|
$3.87M | - | 30 | Compare |
|
CFOR
CFOR
|
- | - | - | - | Compare |
|
GHSI
GHSI
|
- | - | - | - | Compare |
More NBY Analysis
Data updated: Sep 27, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry